| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.091 | 60.332 | 94.392 | 115.324 | 82.952 | 22.984 | 156.586 | 179.013 | 351.633 | 769.943 |
| Total Income - EUR | 16.844 | 60.332 | 94.392 | 162.796 | 82.952 | 24.696 | 156.586 | 179.137 | 351.752 | 769.943 |
| Total Expenses - EUR | 53.202 | 41.164 | 82.527 | 211.108 | 21.653 | 2.917 | 2.958 | 2.936 | 16.426 | 104.740 |
| Gross Profit/Loss - EUR | -36.359 | 19.168 | 11.865 | -48.312 | 61.299 | 21.779 | 153.628 | 176.201 | 335.325 | 665.202 |
| Net Profit/Loss - EUR | -36.862 | 18.502 | 10.632 | -49.940 | 58.811 | 21.081 | 149.592 | 172.691 | 332.553 | 617.525 |
| Employees | 2 | 2 | 2 | 6 | 1 | 0 | 0 | 1 | 1 | 4 |
Check the financial reports for the company - Dr. Levy Y. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40.088 | 37.091 | 60.514 | 9.246 | 9.067 | 8.895 | 8.698 | 8.725 | 8.698 | 17.815 |
| Current Assets | 6.751 | 22.152 | 39.627 | 16.288 | 22.680 | 16.054 | 146.985 | 315.768 | 627.585 | 929.196 |
| Inventories | 3.456 | 2 | 12.023 | 6.330 | 6.208 | 6.090 | 5.955 | 5.973 | 5.955 | 223 |
| Receivables | 668 | 662 | 6.230 | 9.448 | 9.265 | 9.185 | 21.073 | 51.300 | 501.649 | 718.144 |
| Cash | 2.626 | 21.488 | 21.374 | 510 | 7.207 | 779 | 119.958 | 258.494 | 119.981 | 210.828 |
| Shareholders Funds | -65.664 | -46.493 | -35.665 | -84.950 | -24.495 | -2.950 | 146.708 | 319.854 | 392.875 | 898.948 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 112.503 | 105.736 | 135.805 | 110.485 | 56.242 | 27.899 | 8.975 | 4.639 | 243.408 | 48.063 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Levy Y. Srl